Change search
ReferencesLink to record
Permanent link

Direct link
11beta-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues.
Show others and affiliations
2007 (English)In: Am J Physiol Endocrinol Metab, ISSN 0193-1849, Vol. 293, no 4, E1045-52 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2007. Vol. 293, no 4, E1045-52 p.
Keyword [en]
11-beta-Hydroxysteroid Dehydrogenase Type 1/*antagonists & inhibitors, Adipose Tissue; Brown/drug effects/metabolism, Animals, Enzyme Inhibitors/pharmacology, Heart/drug effects, Hypertriglyceridemia/blood/*metabolism, Lipid Metabolism/*drug effects, Lipoproteins; VLDL/*drug effects/*secretion, Liver/*drug effects/metabolism, Male, Muscle; Skeletal/drug effects/metabolism, Myocardium/metabolism, Oxidation-Reduction/drug effects, Rats, Rats; Sprague-Dawley, Triazoles/*pharmacology, Triglycerides/*secretion
URN: urn:nbn:se:umu:diva-6835PubMedID: 17666487OAI: diva2:146505
Available from: 2008-01-11 Created: 2008-01-11 Last updated: 2011-01-11Bibliographically approved

Open Access in DiVA

No full text

Other links


Search in DiVA

By author/editor
Olivecrona, Gunilla
By organisation
Physiological chemistry

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 30 hits
ReferencesLink to record
Permanent link

Direct link